These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26520840)

  • 1. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis.
    Magbanua MJ; Melisko M; Roy R; Sosa EV; Hauranieh L; Kablanian A; Eisenbud LE; Ryazantsev A; Au A; Scott JH; Park JW
    Cancer Res; 2013 Dec; 73(23):7134-43. PubMed ID: 24142343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.
    Cordone I; Masi S; Summa V; Carosi M; Vidiri A; Fabi A; Pasquale A; Conti L; Rosito I; Carapella CM; Villani V; Pace A
    Breast Cancer Res; 2017 Apr; 19(1):46. PubMed ID: 28399903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
    Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
    Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis.
    Tu Q; Wu X; Le Rhun E; Blonski M; Wittwer B; Taillandier L; De Carvalho Bittencourt M; Faure GC
    Lung Cancer; 2015 Nov; 90(2):352-7. PubMed ID: 26386833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid.
    van Bussel MTJ; Pluim D; Bol M; Beijnen JH; Schellens JHM; Brandsma D
    J Neurooncol; 2018 Mar; 137(1):1-10. PubMed ID: 29192390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
    Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
    Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation.
    Allen JE; Patel AS; Prabhu VV; Dicker DT; Sheehan JM; Glantz MJ; El-Deiry WS
    Cancer Res; 2014 May; 74(9):2385-90. PubMed ID: 24614081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of detecting CSF-derived tumor cells in breast cancer patients with leptomeningeal metastasis.
    Li X; Zhang Y; Ding J; Wang M; Li N; Yang H; Wang K; Wang D; Lin PP; Li M; Zhao Z; Liu P
    Oncotarget; 2018 Jan; 9(2):2705-2714. PubMed ID: 29416803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thinprep plus Papanicolaou stain method is more sensitive than cytospin-coupled Wright Giems stain method in cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis from solid tumors.
    Pan Z; Yang G; Wang Y; He H; Pang X; Gao Y; Shi W; Li Y; Dong L; Song Y
    PLoS One; 2015; 10(4):e0122016. PubMed ID: 25850010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
    van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
    Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.
    van Bussel MTJ; Pluim D; Milojkovic Kerklaan B; Bol M; Sikorska K; Linders DTC; van den Broek D; Beijnen JH; Schellens JHM; Brandsma D
    Neurology; 2020 Feb; 94(5):e521-e528. PubMed ID: 31907288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis.
    Le Rhun E; Tu Q; De Carvalho Bittencourt M; Farre I; Mortier L; Cai H; Kohler C; Faure GC
    Med Oncol; 2013 Jun; 30(2):538. PubMed ID: 23504338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and clinical value of epithelial cellular adhesion molecule (EpCAM) mRNA positive circulating tumor cells in metastatic breast cancer].
    Yan Y; Cheng JP; Di LJ; Song GH; Ren J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):275-80. PubMed ID: 22517003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.